GLP-1 and Bioidentical Hormone Replacement Therapy Within a Structured Care Plan
If you are researching GLP-1 medication, bioidentical hormone replacement therapy, or both — you do not need to arrive knowing which is right for you. That is what a comprehensive metabolic and hormonal evaluation determines. What matters right now is that you are looking for a provider who will prescribe with clinical rigor, not convenience.
You already know what careless prescribing looks like. High-volume telehealth platforms that dispense GLP-1s after a brief questionnaire. An OB/GYN who prescribes hormone replacement therapy without evaluating your insulin resistance, your body composition, or your full metabolic profile. You have been looking for something more serious than that.
This is a different model: one provider, one clinical relationship, and every medication — GLP-1, bioidentical hormones, metformin, thyroid support — managed within the full context of your metabolic and hormonal health. Medication is not a standalone treatment. It is a strategic tool used within a structured care plan, prescribed based on evaluation results, and monitored at every visit.
This page explains our clinical approach to prescribing and why the sequence of care determines your results. We serve women across the Portland and Boise metropolitan areas and throughout Oregon and Idaho.
How We Prescribe
Every medication we prescribe — from GLP-1s to bioidentical hormone replacement therapy — follows the same logic: evaluation before intervention. Medication is never a standalone solution; it is one component of a structured program that includes nutrition, exercise, movement, and nervous system support.
The sequence matters because the same medication can produce very different outcomes depending on when it is introduced. A GLP-1 prescribed before the metabolic foundation is in place often produces weight loss at the expense of muscle — the tissue that drives your long-term metabolic durability. Bioidentical hormones prescribed without evaluating the underlying metabolic picture may address symptoms without resolving the dysfunction beneath them.
This sequencing logic is what we call the Adaptive Defense Model (ADM). Your evaluation identifies the specific metabolic and hormonal pattern. The ADM determines which intervention comes first, which comes later, and why the order protects your results.
GLP-1 as Strategic Scaffolding
We prescribe compounded semaglutide and tirzepatide when clinically indicated—not as a first resort, but as a strategic tool within the Acceleration phase of the Metabolic Rebuild.
The Clinical Sequence
GLP-1 is never the first intervention. We spend the first six weeks of the Metabolic Rebuild establishing your foundation—protein, sleep, movement, and stress regulation. Introducing GLP-1 before this foundation is in place leads to weight loss, but often at the expense of muscle. The order determines the quality of the result.
Consistent Monitoring
We track your response biweekly using objective data—body composition, metabolic markers, side effects, and your own experience of how the medication is affecting your daily life. Dosing is adjusted based on your data trends, not on an arbitrary, standard titration schedule.
The Exit Plan
Our goal is metabolic stability that persists after the medication ends, not indefinite GLP-1 dependence.
We define a monitored taper based on your body composition and metabolic stability
Our architecture—resistance training and direct lean mass tracking—ensures you predominantly lose fat, and not the critical muscle tissue that drives your long-term metabolic durability.
By the time you taper, you have the nutritional and metabolic skills to keep the results. This is the fundamental difference between structured care and a GLP-1 mill. A patient who tapers GLP-1 after four months of structured metabolic rebuilding, with acquired metabolic self-management skills and continued clinical oversight, is in a fundamentally different position than a patient who tapers after four months of medication alone.
Bioidentical Hormone Replacement Therapy: The Hormonal Foundation
We prescribe individualized bioidentical hormone replacement therapy (BHRT) sourced from a quality-certified compounding pharmacy. Dosing and delivery methods are tailored to your labs and symptoms—never a one-size protocol.
Individualized Timing
Your metabolic and hormonal health are assessed together from day one — not as separate concerns managed by separate providers. Whether bioidentical hormone replacement therapy is the right starting point, a later intervention, or not indicated at all is determined by your evaluation. You do not need to arrive with that answer.
Your integrated evaluation determines the sequence:
If estrogen decline is driving your metabolic instability, BHRT enters during the Foundation phase of the Metabolic Rebuild.
If your hormonal symptoms are downstream of insulin resistance, we address the metabolic foundation first to produce hormonal improvement before considering additional hormonal refinement with BHRT.
Continuous Clinical Rigor
BHRT is not a once-a-year prescription. We reassess labs at structured intervals and monitor your response at every visit. Unlike the temporary scaffolding of GLP-1s, BHRT is designed as durable, ongoing care to support metabolic stability through perimenopause, menopause and beyond. Lab monitoring, formulation adjustment, and prescribing are part of the ongoing clinical relationship through Active Continuity and Continuity Care.
The Integrated Medical Home
While your OB/GYN provides essential screenings, we manage the integrated picture: your weight, your insulin resistance, your body composition, and your hormone replacement therapy — all under one clinical relationship, with one provider who understands how these systems interact. If you are already on HRT, we can manage your transition to compounded bioidenticals or integrate your current regimen into our metabolic framework.
Two medications. Two different clinical roles.
GLP-1 medication and bioidentical hormone replacement therapy are both part of the clinical model at this practice. They are not interchangeable. They serve different functions, operate on different timelines, and play different roles in the long-term clinical relationship.
GLP-1 Medication
Clinical Role
Scaffolding with an exit plan
Timeline
Accelerated rebuilding phase
The Goal
Stability that persists after a taper
Bioidentical Hormone Replacement Therapy
Clinical Role
Durable foundation for stability
Timeline
Ongoing through menopause and beyond
The Goal
Long-term stewardship of physiology
Shared Logic: Evaluation-based, data-monitored, and sequence-driven
The difference is in the arc: One is designed to resolve the defense; the other is designed to sustain the foundation.
The Integrated Regimen
This is not a medication menu; it is a clinical partnership. While GLP-1s and BHRT are frequent topics of conversation, they are only part of your metabolic infrastructure. We actively manage the "quiet" drivers of metabolic health—thyroid function and insulin sensitivity—while ensuring that any existing prescriptions from other providers are synthesized into one cohesive plan. We don't look at your medications in isolation; we look at how everything interacts to support your health.
The Next Step Is The Same For Everyone
Whether you came to this page researching GLP-1 medication, bioidentical hormone replacement therapy, or both — the pathway forward is the same. The Metabolic Evaluation is where your full metabolic and hormonal picture is mapped, your specific pattern is identified, and prescribing decisions begin. Every medication we prescribe starts here.
We do not prescribe medication prior to the completion of the Metabolic Evaluation, or without the ongoing clinical supervision provided by enrollment in the Metabolic Rebuild. This is how we ensure that every prescription is grounded in your data, sequenced correctly, and monitored carefully.
Schedule a Metabolic Evaluation
$595 · Credited toward the Metabolic Rebuild
A 60-minute intake and comprehensive lab assessment followed by a 45-minute review of findings with specific clinical recommendations.
Schedule a Metabolic EvaluationStart with a Discovery Visit
No charge · 15 minutes
A conversation to talk through what you are experiencing and whether this is the right clinical fit.
Schedule a Discovery Visit